The Center of Medical Innovation and Translational ResearchResearch and Development DepartmentResponsible DepartmentResearch Partner25257F0701Regenerative medicine based on stem-cell technology can possibly treat irreversibly dysfunctional tissues or organs that medicine cannot treat currently. However, the realization of regenerative medicine has faced some significant obstacles, such as cell preparation methods, product standardization, and the costs of manufacturing. The aim of our department is to develop new technologies to manufacture and standardize stem-cell-based products for the advancement of regenerative medicine.B-12Department of Stem Cells and Applied MedicineSAKIMOTO SusumuEndowed Chair Associate ProfessorDepartment of Stem Cells and Applied MedicineROHTO Pharmaceutical Co., Ltd.Development of new technology for the manufacturing, standardization and application of stem cell-based productsRegenerative Medicine Unit For the establishment of regenerative therapies as new standard in medical care.
元のページ ../index.html#26